Stay updated on CAN04 Combined with FOLFIRINOX in Pancreatic Cancer Clinical Trial
Sign up to get notified when there's something new on the CAN04 Combined with FOLFIRINOX in Pancreatic Cancer Clinical Trial page.

Latest updates to the CAN04 Combined with FOLFIRINOX in Pancreatic Cancer Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.SummaryDifference0.1%
- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedThe page has undergone significant content removal, particularly regarding the details of a clinical study for metastatic pancreatic ductal adenocarcinoma, including inclusion and exclusion criteria, which are critical for understanding the study's parameters. Additionally, the revision number has been updated from v2.14.4 to v2.15.0.SummaryDifference35%
- Check30 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.1%
- Check37 days agoChange DetectedThe web page has been updated from version 2.14.2 to version 2.14.3.SummaryDifference0.1%
- Check73 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference1%
- Check87 days agoChange DetectedThe web page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.SummaryDifference1%
Stay in the know with updates to CAN04 Combined with FOLFIRINOX in Pancreatic Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the CAN04 Combined with FOLFIRINOX in Pancreatic Cancer Clinical Trial page.